Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Drizalma Sprinkle
Generic Name
Duloxetine
Active Ingredient
DuloxetineCategory
Other
Salt Form
Hydrochloride
Variants
4
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Drizalma Sprinkle, you must consult a qualified healthcare professional.
| 20 mg/1 | CAPSULE, DELAYED RELEASE | ORAL | 47335-616 |
Detailed information about Drizalma Sprinkle
Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder, generalized anxiety disorder, and chronic pain conditions such as fibromyalgia and diabetic peripheral neuropathy.
The dosage of Duloxetine is highly individualized and depends on the specific condition being treated. Healthcare providers typically start with a lower dose and gradually increase it to minimize side effects.
Duloxetine is approved for use in pediatric populations for specific conditions:
Duloxetine is not recommended for patients with end-stage renal disease or severe renal impairment (estimated Creatinine Clearance < 30 mL/min). This is because the drug and its metabolites can accumulate to toxic levels when kidney function is severely compromised.
Duloxetine should generally be avoided in patients with chronic liver disease or cirrhosis. Because the liver is the primary site of metabolism, impaired liver function can lead to significantly higher blood levels of the drug and an increased risk of hepatotoxicity (liver damage).
No routine dosage adjustment is required based solely on age. However, healthcare providers exercise caution when increasing doses in the elderly, as they may be more sensitive to side effects like hyponatremia (low blood sodium) or falls due to dizziness.
To ensure the medication works effectively and safely, follow these specific instructions:
If you miss a dose of Duloxetine, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Never take two doses at once to make up for a missed one, as this increases the risk of toxicity.
An overdose of Duloxetine can be life-threatening. Symptoms of overdose may include extreme drowsiness, vomiting, rapid heart rate (tachycardia), seizures, dizziness, and signs of serotonin syndrome (such as agitation, hallucinations, or fever). If an overdose is suspected, contact emergency services or a poison control center immediately.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking the medication without medical guidance, as sudden discontinuation can cause withdrawal symptoms.
Side effects are most common during the first few weeks of treatment as the body adjusts to the increased levels of serotonin and norepinephrine. Most common side effects include:
Duloxetine is a powerful medication that affects central nervous system chemistry. It is not suitable for everyone. Before starting treatment, you must provide your healthcare provider with a complete medical history, especially if you have a history of liver disease, kidney disease, glaucoma, seizures, or bleeding disorders. It is also vital to disclose any history of substance abuse or suicidal thoughts.
Suicidal Thoughts and Behaviors: Antidepressants, including Duloxetine, may increase the risk of suicidal thoughts or actions in children, teenagers, and young adults within the first few months of treatment or when the dose is changed. This medication is not FDA-approved for use in treating depression in pediatric patients. Patients of all ages should be monitored for clinical worsening and emergence of suicidality.
Certain drug combinations are extremely dangerous and must be avoided entirely:
There are specific circumstances where Duloxetine must never be used because the risks far outweigh any potential benefits:
Duloxetine is classified under the newer FDA labeling system which requires a detailed summary of risks rather than the old 'Category' system.
Duloxetine is a potent inhibitor of neuronal serotonin (5-HT) and norepinephrine (NE) reuptake. It works by binding to the transport proteins responsible for the reabsorption of these neurotransmitters from the synaptic cleft back into the presynaptic nerve terminal. By inhibiting these transporters, Duloxetine increases the concentration of 5-HT and NE in the synapse, thereby enhancing neurotransmission. It has a high affinity for the serotonin transporter (SERT) and the norepinephrine transporter (NET), but it does not significantly bind to muscarinic, histamine H1, or alpha-adrenergic receptors, which contributes to its relatively favorable side effect profile compared to older antidepressants.
Common questions about Drizalma Sprinkle
Duloxetine is a versatile medication FDA-approved for several conditions including Major Depressive Disorder and Generalized Anxiety Disorder. It is also highly effective for chronic pain conditions such as Fibromyalgia, Diabetic Peripheral Neuropathic Pain, and chronic musculoskeletal pain. By increasing levels of serotonin and norepinephrine, it helps regulate both mood and the body's internal pain-dampening systems. Some doctors may also prescribe it off-label for other types of nerve pain or stress incontinence. Always consult your healthcare provider to see if your specific symptoms warrant the use of Duloxetine.
The most frequently reported side effect of Duloxetine is nausea, which affects about 20% of patients but usually improves after a week or two. Other common side effects include dry mouth, sleepiness, fatigue, and a decrease in appetite. Some people may also experience increased sweating, constipation, or blurred vision during the early stages of treatment. While these are often mild, they can be bothersome; taking the medication with food or adjusting the time of day you take it can sometimes help. If side effects persist or become severe, you should contact your doctor to discuss a possible dose adjustment.
It is strongly recommended that you avoid heavy alcohol consumption while taking Duloxetine. Both Duloxetine and alcohol are processed by the liver, and combining them significantly increases the risk of severe liver injury or even liver failure. Furthermore, alcohol is a central nervous system depressant that can worsen the drowsiness caused by Duloxetine and counteract the drug's effects on depression and anxiety. Even moderate drinking can increase the risk of dizziness and falls. Always discuss your alcohol intake honestly with your healthcare provider before starting this medication.
The use of Duloxetine during pregnancy requires a careful discussion with your doctor regarding the risks and benefits. While there is no definitive evidence that it causes major birth defects, exposure late in the third trimester may lead to complications for the newborn, such as breathing difficulties or withdrawal symptoms. However, untreated depression or chronic pain during pregnancy also poses significant risks to both the mother and the baby. Your healthcare provider will help you decide if the clinical need for the medication outweighs the potential risks to the fetus. There are also pregnancy registries available to monitor the health of babies born to mothers taking antidepressants.
The timeline for Duloxetine's effects varies depending on the condition being treated. For chronic pain conditions like fibromyalgia or diabetic neuropathy, some patients may feel a reduction in pain within 1 to 2 weeks. For depression and anxiety, it typically takes longer, with initial improvements often appearing in 2 to 4 weeks and the full therapeutic benefit taking 6 to 8 weeks. It is important to continue taking the medication as prescribed even if you do not feel better right away. If you have not noticed any improvement after 6 weeks, your doctor may consider adjusting your dose.
You should never stop taking Duloxetine suddenly without consulting your healthcare provider. Abruptly stopping the medication can lead to 'discontinuation syndrome,' which includes symptoms like dizziness, nausea, headache, irritability, and 'brain zaps' (sensations resembling electric shocks). These symptoms can be very uncomfortable and may last for several weeks. To stop the medication safely, your doctor will provide a tapering schedule to slowly lower your dose over time. This allows your brain chemistry to adjust gradually and minimizes withdrawal symptoms.
If you miss a dose of Duloxetine, you should take it as soon as you remember. However, if it is nearly time for your next scheduled dose, you should skip the missed dose and simply take your next one at the regular time. Do not take two doses at once to 'catch up,' as this can increase your risk of side effects or toxicity. Keeping your medication in a pill organizer or setting a daily alarm can help you stay consistent with your dosing schedule. If you frequently miss doses, talk to your doctor about strategies to help you remember.
Weight changes with Duloxetine can be variable and depend on the duration of treatment. In short-term clinical trials, many patients actually experienced a slight weight loss due to decreased appetite and nausea. However, long-term studies suggest that some patients may experience modest weight gain over several months or years of therapy. This is a common feature of many medications that affect serotonin levels. If you are concerned about weight changes, your doctor can help you develop a plan for monitoring your weight and maintaining a healthy lifestyle while on the medication.
Duloxetine has several significant drug interactions, so it is vital to inform your doctor of everything you are taking. It should never be taken with MAOIs, and it must be used with caution alongside other serotonergic drugs like SSRIs or triptans due to the risk of Serotonin Syndrome. It can also increase the risk of bleeding if taken with aspirin, NSAIDs (like ibuprofen), or blood thinners like warfarin. Because Duloxetine is processed by specific liver enzymes, other drugs that inhibit those enzymes can cause Duloxetine levels to rise dangerously. Always check with a pharmacist before starting any new over-the-counter supplement or medication.
Yes, Duloxetine is widely available as a generic medication, which is typically much more affordable than the brand-name version, Cymbalta. Generic versions are required by the FDA to have the same active ingredient, strength, dosage form, and route of administration as the brand-name drug. They must also prove 'bioequivalence,' meaning they work in the body in the same way and provide the same clinical benefit. Most insurance plans cover generic Duloxetine. If you have concerns about switching between brand and generic, discuss them with your pharmacist or healthcare provider.
Other drugs with the same active ingredient (Duloxetine)
> Warning: Stop taking Duloxetine and call your doctor or emergency services immediately if you experience any of the following:
While many patients take Duloxetine for years without issues, long-term use requires monitoring. Potential long-term effects include changes in blood pressure (it can cause a slight sustained increase) and potential weight changes. Some studies suggest a risk of bone fractures in older adults, likely due to increased fall risk from dizziness. Regular follow-ups with a healthcare provider are necessary to ensure the benefits continue to outweigh the risks.
Duloxetine carries an FDA Black Box Warning—the most serious type of warning—regarding Suicidality in Children, Adolescents, and Young Adults.
Studies have shown that antidepressants increase the risk of suicidal thinking and behavior in children, adolescents, and young adults (ages 18-24) during initial treatment and dose changes. This risk was not seen in adults over age 24. Patients of all ages who are started on Duloxetine should be monitored closely for worsening of depression, suicidal thoughts, or unusual changes in behavior (such as anxiety, agitation, panic attacks, or impulsivity). Families and caregivers should be alert to these changes and report them to the prescribing doctor immediately.
Report any unusual symptoms to your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA at 1-800-FDA-1088.
Healthcare providers will typically monitor the following during Duloxetine therapy:
Duloxetine may cause sedation, dizziness, or blurred vision. Until you know how the medication affects you, avoid driving a car or operating heavy machinery. The risk of impairment is increased if Duloxetine is taken with alcohol or other sedating medications.
Patients taking Duloxetine should avoid heavy alcohol consumption. Combining Duloxetine with alcohol significantly increases the risk of severe liver injury. Additionally, alcohol can worsen the sedative effects of the medication and exacerbate depression or anxiety symptoms.
Do not stop taking Duloxetine abruptly. Sudden discontinuation can lead to "Discontinuation Syndrome." Symptoms include dizziness, nausea, headache, paresthesia (tingling/burning sensations often described as 'brain zaps'), anxiety, and irritability. To stop the medication safely, your doctor will provide a tapering schedule to gradually reduce the dose over several weeks.
> Important: Discuss all your medical conditions and lifestyle habits with your healthcare provider before starting Duloxetine to ensure the medication is safe for you.
Duloxetine does not typically interfere with most standard laboratory tests. However, there have been rare reports of false-positive urine drug screen results for amphetamines in patients taking Duloxetine when using certain immunoassay methods. If a drug screen is required, a more specific confirmatory test (like GC/MS) should be used.
Mechanism of Interactions: Most Duloxetine interactions occur through either Pharmacodynamic pathways (where two drugs have similar effects, like both increasing serotonin or both thinning the blood) or Pharmacokinetic pathways (where one drug interferes with the liver enzymes, specifically CYP1A2 and CYP2D6, that break down the other drug).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Keep a current list and share it with every healthcare provider you visit.
Relative contraindications require a careful risk-benefit analysis by a physician:
While there is no established cross-sensitivity between Duloxetine and other SNRIs (like venlafaxine), patients who have had severe allergic reactions to other antidepressants should be monitored closely during the initiation of Duloxetine therapy.
> Important: Your healthcare provider will evaluate your complete medical history, including your kidney and liver function, before prescribing Duloxetine to ensure it is a safe option for you.
Duloxetine is excreted into human breast milk, but the amount is relatively low (approximately 0.14% of the maternal dose). While there are no well-documented adverse effects on nursing infants, healthcare providers recommend monitoring the infant for symptoms like sedation, poor feeding, or poor weight gain. For many women, the benefits of maintaining mental health or pain control during the postpartum period outweigh the small risk to the infant.
Clinical studies have included a significant number of patients over age 65.
As previously noted, Duloxetine should be avoided in patients with severe renal impairment (CrCl < 30 mL/min). For patients with mild to moderate renal impairment, no specific dose adjustment is typically required, but they should be monitored for side effects.
Duloxetine is extensively metabolized in the liver. In patients with hepatic impairment, the drug stays in the body much longer and reaches higher concentrations. Due to the inherent risk of Duloxetine-induced liver injury, it should not be used in patients with any degree of hepatic insufficiency or chronic liver disease.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding before starting Duloxetine.
| Parameter | Value |
|---|---|
| Bioavailability | 30% to 80% (Average 50%) |
| Protein Binding | >90% (Primarily Albumin) |
| Half-life | 12 hours (Range 8-17 hours) |
| Tmax | 6 hours (10 hours with food) |
| Metabolism | Hepatic (CYP1A2 and CYP2D6) |
| Excretion | Renal 70%, Fecal 20% |
Duloxetine is a member of the Selective Serotonin and Norepinephrine Reuptake Inhibitor (SNRI) class. Related medications in this class include venlafaxine (Effexor), desvenlafaxine (Pristiq), and milnacipran (Savella). Unlike SSRIs, which only target serotonin, SNRIs provide a broader range of action that is particularly useful for treating the physical symptoms of pain alongside mood disorders.